Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

technology-rich in the field of crystallization.  Our intellectual assets include issued, foundational patents involving both crystal form screening methods and production-scale continuous crystallization processes.  We have multiple, complementary techniques so that customers can access crystallization surfaces that are as diverse as the chemical species for which crystallization is commercially important.

Please contact us to discuss your needs, and we will use our diverse selection of crystallization tools to create a solution.

 

Challenges

 

 

Control of the size, shape, and structure of crystalline active pharmaceuticals ingredients remains a challenge in R&D and production.

Screening Solutions

 

 

Screening with crystallization platforms based on self assembled monolayers (SAMs) is fast and mass efficient.

Manufacturing Services

 

 

Work with us to explore continuous crystallization processes that replace costly batch methods and give better control of crystal size distribution.